Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Structure Therapeutics Inc. | 59,073 | reported | 19 Mar 2026 | tx 10+432,501−10,857 |
| OnKure Therapeutics, Inc. | 55,225 | reported | 28 Aug 2023 | tx 6+350,625−31,250 |
| Esperion Therapeutics, Inc. | 31,000 | reported | 28 Jan 2021 | tx 2+38,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | GRANT_AWARD | Structure Therapeutics Inc. | 47,706 | 0.00 USD | |
| 19 Mar 2026 | GRANT_AWARD | Structure Therapeutics Inc. | 59,073 | 0.00 USD | deriv |
| 03 Mar 2026 | TAX_WITHHOLDING | Structure Therapeutics Inc. | 4,836 | 20.99 USD | |
| 20 May 2025 | GRANT_AWARD | Structure Therapeutics Inc. | 225 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | Structure Therapeutics Inc. | 237 | 0.00 USD | deriv |
| 18 Sept 2025 | TAX_WITHHOLDING | Structure Therapeutics Inc. | 6,021 | 7.74 USD | |
| 15 Mar 2025 | GRANT_AWARD | Structure Therapeutics Inc. | 51,048 | 0.00 USD | |
| 15 Mar 2025 | GRANT_AWARD | Structure Therapeutics Inc. | 124,032 | 0.00 USD | deriv |
| 18 Sept 2024 | GRANT_AWARD | Structure Therapeutics Inc. | 67,290 | 0.00 USD | |
| 18 Sept 2024 | GRANT_AWARD | Structure Therapeutics Inc. | 82,890 | 0.00 USD | deriv |
| 28 Aug 2023 | SALE | OnKure Therapeutics, Inc. | 15,625 | 6.28 USD | |
| 28 Aug 2023 | EXERCISE | OnKure Therapeutics, Inc. | 15,625 | 1.80 USD | |
| 28 Aug 2023 | EXERCISE | OnKure Therapeutics, Inc. | 15,625 | 0.00 USD | deriv |
| 09 Dec 2022 | GRANT_AWARD | OnKure Therapeutics, Inc. | 125,000 | 0.00 USD | deriv |
| 12 Nov 2021 | GRANT_AWARD | OnKure Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 12 Nov 2021 | GRANT_AWARD | OnKure Therapeutics, Inc. | 180,000 | 0.00 USD | deriv |
| 28 Jan 2021 | GRANT_AWARD | Esperion Therapeutics, Inc. | 7,000 | 0.00 USD | |
| 28 Jan 2021 | GRANT_AWARD | Esperion Therapeutics, Inc. | 31,000 | 0.00 USD | deriv |